Log In
Print this Print this

Deflux, hyaluronic acid/dextranomer

  Manage Alerts
Collapse Summary General Information
Company Galderma S.A.
DescriptionGel of dextranomer microspheres in a carrier gel of non-animal stabilized hyaluronic acid (HA)
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard IndicationVesicoureteral reflux
Indication DetailsTreat children with vesicoureteral reflux
Regulatory Designation
PartnerValeant Pharmaceuticals International Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today